04.05.2024 | Development of Genetically Engineered Mouse Models for NF1-associated Optic Pathway Glioma
04.05.2024 | A Phase 3 Randomized Study of Selumetinib versus Carboplatin and Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 (NF1) Associated Low-Grade Glioma (LGG)
03.27.2024 Detroit Future City Releases New Report: “Keeping Your Family Home: Addressing the Challenges of Inherited Properties in Detroit” Read
03.26.2026 Five Years In: Rocket Community Fund and Gilbert Family Foundation Share Progress on $500 Million Commitment to Building Opportunity in Detroit Neighborhoods Read